 "PE/VC investments in pharma companies grow 3.5X in 2020, cross $1 bn mark")
Private Equity (PE)/Venture Capital (VC) investments in pharmaceutical companies have grown by more than 3.5 times in 2020 and for the first time crossed $1 billion to touch $1.69 billion during January to September 2020.
According to experts, the industry enjoys respect and enduring relationships among investors on the back of good exits. Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma imports from China.
During January to September 2020, the sector attracted $1.69 billion (in 19 deals) as compared to $368
